Post-earnings recap
Reported
Mon, May 13, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a loss of $0.22 per share for Q1 2019, with no revenue reported. The stock reacted negatively, declining by 3.4%. The lack of guidance and commentary from management may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.22 | N/A | — |
| Revenue | $— | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.